Javelin Says Hospira Breached $145M Merger Deal
Javelin Pharmaceuticals Inc. is seeking to force Hospira Inc. to complete its proposed $145 million acquisition of the painkiller company and make good on its alleged promise to furnish Javelin with...To view the full article, register now.
Already a subscriber? Click here to view full article